News

Filter

Threshold initiates Ph II glufosfamide trial

16-04-2007

California, USA-based Threshold Pharmaceuticals has initiated patient enrollment for a Phase II clinical…

FDGFludeoxyglucose F 18 Injection

Epigenomics enters cancer accord with Stanford University

19-06-2006

Epigenomics AG, a Germany-based molecular diagnostics company developing tests based on DNA methylation,…

FDGFludeoxyglucose F 18 Injection

COMPANY SPOTLIGHT

Menarini

Back to top